SIFTAXYS
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79423293
- Registration number
- 8112974
- Mark type
- Stylized text
- Filed
- 21 Mar 2025
- Published for opposition
- 09 Dec 2025
- Registered
- 27 Jan 2026
- Attorney of record
- Pina M. Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial community, namely, for the treatment of dysbiosis, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases
- Class 010 — Medical apparatus: Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparations, namely, a kit comprising a suspension bag and administration tube set, sold empty; Drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, namely, syringes, infusion sets, implantable devices sold empty; drug delivery devices to treat gut microbiome-related disorders, cancers, neurological diseases, psychiatric diseases, gastrointestinal diseases, metabolic diseases, inflammatory diseases, autoimmune diseases, infectious diseases, in the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication
Owner
- MAAT PHARMA, FR
- MAAT PHARMA, FR
- MAAT PHARMA, FR
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 11 Dec 2025 — NOTIFICATION PROCESSED BY IB
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 25 Nov 2025 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 13 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 12 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 12 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 12 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 29 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED